Skip to content

Comparative Study on the Treatmeat of White Stretch Marks Using CO2 Laser Versus CO2 Laser Combined with stromal vascular fraction gel

Comparative Study on the Treatmeat of White Stretch Marks Using CO2 Laser Versus CO2 Laser Combined with stromal vascular fraction gel

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104451
Enrollment
Unknown
Registered
2025-06-17
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae gravidarum, White striae gravidarum

Interventions

Treatment Group:The patient underwent CO? laser therapy on the left side and CO? laser plus SVF gel graft treatment on the right side for a total of 3 treatments, 1 every 3 months, the first procedure

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 - 49 years old (including 18 and 49 years old), female. 2.Fitzpatrick skin types are II - V, with types III and IV being preferred. 3.Clinically diagnosed with white striae distensae on the abdomen, and the condition is stable (with stable body weight within 4 - 6 months before treatment).

Exclusion criteria

Exclusion criteria: 1.Suffering from red striae distensae. 2.Suffering from multiple systemic diseases, such as diabetes, hypertension, Cushing's syndrome, goiter, asthma, connective tissue diseases, bleeding or coagulation disorders, immunodeficiency, immunosuppression, platelet disorders, wound healing problems, etc. 3.Having a history of keloid or hypertrophic scar, a tendency to post-inflammatory hyperpigmentation (PIH), precancerous or malignant lesions, active infections, respiratory diseases, or unrealistic expectations. 4.In special physiological states, such as pregnant women and lactating women. 5.Having a history of using specific medications, such as local or systemic steroids, retinoids, anticoagulants, hormone replacement therapy, oral contraceptives, immunosuppressants, etc., and those who have used related medications or received related treatments within 12 months. 6.Those who cannot cooperate with the treatment.

Design outcomes

Primary

MeasureTime frame
The length of striae gravidarum before and after treatment;Stretch mark area and color before and after stretch mark treatment;Adverse reactions after treatment;

Secondary

MeasureTime frame
Patient satisfaction;

Countries

China

Contacts

Public ContactWang Chen

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

wangchen2369@163.com+86 21 34206890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026